SCHEMBL3393357

SCHEMBL3393357

CC(=O)N1c2ccc(NC(=O)c3cc(C)cc(C)c3)cc2C(C)(c2ccc(OCCN3CCOCC3)cc2)CC1(C)C

nearest known ligand 0.56

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FSHR P23945 17/20 0.56
KDR P35968 2/20 0.46
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3396056 0.92 FSHR (0.55) FSHRKDRALDH1A1
SCHEMBL3394823 0.92 FSHR (0.65) FSHRKDRALDH1A1
SCHEMBL3398201 0.90 FSHR (0.59) FSHRKDRALDH1A1
SCHEMBL3425195 0.90 FSHR (0.58) FSHRKDR
SCHEMBL3396766 0.89 FSHR (0.58) FSHRKDRKDM4EALDH1A1
SCHEMBL4600077 0.89 FSHR (0.54) FSHRKDR
SCHEMBL3397813 0.87 FSHR (0.54) FSHRKDRALDH1A1
SCHEMBL3393344 0.87 FSHR (0.59) FSHRKDR
SCHEMBL4601614 0.86 FSHR (0.56) FSHR
SCHEMBL3396761 0.86 FSHR (0.51) FSHRKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7674909-B2 Biphenyl-4-carboxylic acid {1-acetyl-4-[4-(2-dimethylammo-ethoxy-phenyl]-2,2,4-trimethyl-1,2,3,4-tetrahydro-quinolin-6-yl}-amide; fertility regulation; follicle stimulating hormone (FSH) N.V. ORGANON (NL) 2010-03-09 US disclosed
EP-1578727-B1 TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS FSH RECEPTOR MODULATORS ORGANON NV (NL) 2008-04-16 EP disclosed
US-20060167047-A1 Tetrahydorquinoline derivatives and their use as fsh receptor modulators MERCK SHARP & DOHME B.V. (NL) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167047-A1 Tetrahydorquinoline derivatives and their use as fsh receptor modulators FSHR, GNRHR, LHCGR FSHR 1/4885KDR 254/4885KDM4E 445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.